F-18 fluorodeoxyglucose imaging to differentiate the res-ponse to cardiac conduction system pacing in patients with pacing induced cardiomyopathy
Yu ZHANG1
Xiao-Hong ZHOU2
Yang YE3
Zhong-Ke HUANG1
Guo-Sheng FU3
1.Department of Nuclear Medicine,Sir Run Run Shaw Hospital,Zhejiang University School of Medicine,No;3.Qingchun East Road,Hangzhou,Zhejiang,China2.CRM Research and Technology,Medtronic,Inc.,MN,USA3.Department of Cardiology,Sir Run Run Shaw Hospital,College of Medicine,Zhejiang University,No.3 Qing chun East Road,Hangzhou,Zhejiang,China;Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province,Hangzhou,China
摘要：Pacing-induced cardiomyopathy(PICM)resultsfrom the detrimental effect of frequent rightventricular pacing.[1]The diagnosis relies on a combination of pacing-associated ventricular dyschrony manifested with ECG wide LBBB-pattern QRS duration and clinical assessment,imaging studies.Conduction system pacing(CSP),such as His bundle pacing(HBP)and left bundle branch pacing(LBBP),may help to pre-vent PICM,[2]but the criteria for optimal patient selection remain inadequately defined.
机标关键词：imagingsystemwithcardiaccardiomyopathyconductiondeoxyglucosedifferentiate
论文发表日期：2025-03-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：4( 411-414 )